Systane: payments to doctors
Payments that named Systane as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $775K
- Providers
- 678
- Transactions
- 1,274
- Average per transaction
- $608
The per-transaction average — $608 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 678 providers the average total is $1,143, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Alcon | $549,702 | 70.9% |
| Alcon Research LLC | $225,118 | 29.1% |